Document is current
Any future updates will be listed below
-
Authors
Koberschinski, Jonas Janik Ralf https://orcid.org/0009-0008-9633-5601
Reinwald, Mark https://orcid.org/0000-0002-6506-2136
de Wit, Maike https://orcid.org/0000-0001-5222-7133
Kiderlen, Til Ramón https://orcid.org/0000-0003-3158-9527
-
Funding
Funding for this research was provided by:
Pfizer Pharma GmbH (54501551)
Medizinische Hochschule Brandenburg CAMPUS GmbH
- License Information
-
More Information
Article History
Received: 3 May 2024
Accepted: 10 November 2024
First Online: 16 December 2024
Declarations
:
: By ethics committee of the Brandenburg Medical School as part of a broader study context. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
: Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent regarding publishing their data.
: This original EVO study was funded by Pfizer Pharma GmbH as an investigator-initiated trial. Pfizer did not engage in any step of the study conduct, analysis or write-up of this study.
